Energetic Basis for Heart Failure

Heart Failure: A Companion to Braunwald's Heart Disease Expert Consult

Volumn , Issue , 2010, Pages 103-118

  Ingwall, Joanne S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85133981329     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5895-3.10007-5     Document Type: Chapter

References (117)

1. deGoma E.M., Vagelos R.H., Fowler M.B., et al. Emerging therapies for the management of decompensated heart failure: From bench to bedside. J Am Coll Cardiol 2006, 48:2397-2409.
2. Dyck J.R.B., Lopaschuk G.D. AMPK alterations in cardiac physiology and pathology: enemy or ally?. J Physiol 2006, 574(1):95-112.
3. Dzeja P.P., Chung S., Terzic A. Integration of adenylate kinase, glycolytic and glycogenolytic circuits in cellular energetics. Molecular system bioenergetics: energy for life 2007, Wiley-VCH, Weinheim, Germany. V. Saks (Ed.).
4. Finck B.N., Kelly D.P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 2006, 116(3):615-622.
5. Fragasso G. Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure. J Clin Pract 2007, 61(4):603-610.
6. Gustafsson A.B., Gottlieb R.A. Heart mitochondria: gates of life and death. Cardiovasc Res 2007, 77:334-343.
7. Huss J.M., Kelly D.P. Nuclear receptor signaling and cardiac energetics. Circ Res 2004, 95(6):568-578.
8. Huss J.M., Kelly D.P. Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest 2005, 115(3):547-555.
9. Ingwall J.S. Energetics of the failing heart: new insights using genetic modification in the mouse. Archives Des Maladies Du Coeur Et Des vaisseaux 2006, 99(9):839-847.
10. Ingwall J.S., Weiss R.G. Is the failing heart energy starved?. Circ Res 2004, 95(2):135-145.
11. Ingwall J.S. On the hypothesis that the failing heart is energy starved: lessons learned from the metabolism of ATP and creatine. Curr Hypertens Rep 2006, 8(6):457-464.
12. Kodde I.F., van der Stok J., Smolenski R.T., et al. Metabolic and genetic regulation of cardiac energy substrate preference. Comp Biochem Physiol A Mol Integr Physiol 2006, 146:26-39.
13. 2+ and its effects on energetics and redox balance in normal and failing heart. J Bioener Biomembr 2009, 41(2):127-132.
14. Maack C., O'Rourke B. Excitation-contraction coupling and mitochondrial energetics. Basic Res Cardiol 2007, 102:369-392.
15. Marin-Garcia J., Goldenthal M.J. Mitochondrial centrality in heart failure. Heart Fail Rev 2008, 13:137-150.
16. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med 2007, 356(11):1140-1151.
17. Stanley W.C., Recchia F.A., Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005, 85(3):1093-1129.
18. Taegtmeyer H., Wilson C.R., Razeghi P., et al. Metabolic energetics and genetics in the heart. Ann N Y Acad Sci 2005, 1047:208-218.
19. Taha M., Lopaschuk G.D. Alterations in energy metabolism in cardiomyopathies. Ann Med 2007, 39(8):594-607.
20. Tsutsui H. Mitochondrial oxidative stress and heart failure. Intern Med 2006, 45(13):809-813.
21. van Bilsen M., Smeets P.J., Gilde A.J., et al. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?. Cardiovasc Res 2004, 61(2):218-226.
22. Ventura-Clapier R.F., Garnier A., Veksler V. Energy metabolism in heart failure. J Physiol 2004, 555:1-15.
23. Young L.H., Li J., Baron S.J., et al. AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med 2005, 15(3):110-118.
24. 31P NMR magnetization transfer study. J Biol Chem 1985, 260(6):3512-3517.
25. De Sousa E., Veksler V., Minajeva A., et al. Subcellular creatine kinase alterations. Implications in heart failure. Circ Res 1999, 85(1):68-76.
26. Balaban R.S., Kantor H.L., Katz L.A., et al. Relation between work and phosphate metabolite in the in vivo paced mammalian heart. Science 1986, 232(4754):1121-1123.
27. Gong G., Liu J., Liang P., et al. Oxidative capacity in failing hearts. Am J Physiol Heart Circ Physiol 2003, 285:541-548.
28. Ingwall J.S. ATP and the heart 2002, Kluwer Academic, Norwell MA, Boston.
29. Ingwall J.S., Kramer M.F., Fifer M.A., et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 1985, 313(17):1050-1054.
30. Nascimben L., Ingwall J.S., Pauletto P., et al. Creatine kinase system in failing and nonfailing human myocardium. Circulation 1996, 94(8):1894-1901.
31. Tian R., Nascimben L., Kaddurah-Daouk R., et al. Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol 1996, 28(4):755-765.
32. Degens H., de Brouwer K.F., Gilde A.J., et al. Cardiac fatty acid metabolism is preserved in the compensated hypertrophic rat heart. Basic Res Cardiol 2006, 101(1):17-26.
33. Lei B., Lionetti V., Young M.E., et al. Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. J Mol Cell Cardiol 2004, 36(4):567-576.
34. Sorokina N., O'Donnell J.M., McKinney R.D., et al. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts. Circulation 2007, 115:2033-2041.
35. Osorio J.C., Stanley W.C., Linke A., et al. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation 2002, 106(5):606-612.
36. O'Donnell J.M., Fields A.D., Sorokina N., et al. The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover. J Mol Cell Cardiol 2008, 44(2):315-322.
37. Nain S., Ling B., Alcorn J., et al. Biochemical factors limiting myocardial energy in a chicken genotype selected for rapid growth. Comp Biochem Physiol 2008, 149(1):36-43.
38. Shen W., Asai K., Uechi M., et al. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation 1999, 100:2113-2118.
39. Zimmer H.G., Trendelenburg C., Kammermeier H., et al. De novo synthesis of myocardial adenine nucleotides in the rat. Acceleration during recovery from oxygen deficiency. Circ Res 1973, 32(5):635-642.
40. Wu F., Zhang J., Beard D.A. Experimentally observed phenomena on cardiac energetics in heart failure emerge from simulations of cardiac metabolism. Proc Natl Acad Sci U S A 2009, 106(17):7143-7148.
41. Neill W.A., Ingwall J.S. Stabilization of a derangement in adenosine triphosphate metabolism during sustained, partial ischemia in the dog heart. J Am Coll Cardiol 1986, 8(4):894-900.
42. Bishop S.P., Altschuld R.A. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol 1970, 218(1):153-159.
43. Abraham M.R., Selivanov V.A., Hodgson D.M., et al. Coupling of cell energetics with membrane metabolic sensing. Integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knock-out. J Biol Chem 2002, 277(27):24427-24434.
44. Hoyer K., Krenz M., Robbins J., et al. Shifts in the myosin heavy chain isozymes in the mouse heart result in increased energy efficiency. J Mol Cell Cardiol 2007, 42(1):214-221.
45. Radke M.H., Peng J., Wu Y., et al. Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy. Proc Natl Acad Sci U S A 2007, 104(9):3444-3449.
46. Allard M.F., Parsons H.L., Saeedi R., et al. AMPK and metabolic adaptation by the heart to pressure overload. Am J Physiol Heart Circ Physiol 2007, 292:140-148.
47. Allard M.F., Schonekess B.O., Henning S.L., et al. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 1994, 267(2 pt 2):H742-H750.
48. Nascimben L., Ingwall J., Lorell B., et al. Mechanisms for increased glycolysis in the hypertrophied rat heart. Hypertension 2004, 44:662-667.
49. Neglia D., De Caterina A., Marraccini P., et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2007, 293:H3270-H3278.
50. Tian R., Abel E.D. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 2001, 103(24):2961-2966.
51. 31P NMR spectroscopic study. Circulation 1995, 92:1274-1283.
52. 31P-MRS study. Circulation 1996, 94(5):1089-1100.
53. Chandler M.P., Kerner J., Huang H., et al. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. Am J Physiol Heart Circ Physiol 2004, 287(4):H1538-H1543.
54. Tian R., Musi N., D'Agostino J., et al. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 2001, 104(14):1664-1669.
55. Luptak I., Balschi J.A., Xing Y., et al. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization. Circulation 2005, 112(15):2339-2346.
56. Liao R., Jain M., Cui L., et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure due to pressure-overload in mice. Circulation 2002, 106:2125-2131.
57. Kong S.W., Bodyak N., Yue P., et al. Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats. Physiol Genomics 2005, 21:31-42.
58. Murakami Y., Zhang Y., Cho Y.K., et al. Myocardial oxygenation during high work states in hearts with postinfarction remodeling. Circulation 1999, 99(7):942-948.
59. Murray A.J., Cole M.A., Lygate C.A., et al. Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. J Mol Cell Cardiol 2008, 44:694-700.
60. Murray A.J., Edwards L.M., Clarke K. Mitochondria and heart failure. Curr Opin Clin Nutr Metab Care 2007, 10:704-711.
61. Sheeran F.L., Pepe S. Energy deficiency in the failing heart: linking increased reactive oxygen species and disruption of oxidative phosphorylation rate. Biochim Biophys Acta 2006, 1757:543-552.
62. Martin M., Gomez M.A., Guillen F., et al. Myocardial carnitine and carnitine palmitoyltransferase deficiencies in patients with severe heart failure. Biochim Biophys Acta 2000, 1502:330-336.
63. Rennison J.H., McElfresh T.A., Okere I.C., et al. Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure. Cardiovasc Res 2008, 79:331-340.
64. Pound K.M., Sorokina N., Ballal K., et al. Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy. Circ Res 2009, 104(6):805-812.
65. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 2003, 24(1):78-90.
66. Garnier A.Z.J., Fortin D., N'Guessan B., et al. Control by circulating factors of mitochondrial function and transcription cascade in heart failure. A role for endothelin-1 and angiotensin-II. Circ Heart Fail 2009, (in press).
67. Garnier A., Fortin D., Delomenie C., et al. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 2003, 551(pt 2):491-501.
68. Huss J.M., Imahashi K., Dufour C.R., et al. The nuclear receptor ERR? is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab 2007, 6:25-37.
69. Sano M., Izumi Y., Helenius K., et al. Ménage à trois 1 is critical for the transcriptional function of PPAR? coactivator 1. Cell Metab 2007, 5:129-142.
70. Sano M., Wang S.C., Shirai M., et al. Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure. EMBO J 2004, 23(17):3559-3569.
71. Burkart E.M., Sambandam N., Han X., et al. Nuclear receptors PPAR?/? and PPAR? direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest 2007, 117(12):3930-3939.
72. Son N.H., Park T.S., Yamashita H., et al. Cardiomyocyte expression of PPAR? leads to cardiac dysfunction in mice. J Clin Invest 2007, 117(10):2791-2801.
73. Dufour C.R., Wilson B.J., Huss J.M., et al. Genome-wide orchestration of cardiac function by the orphan nuclear receptors ERR? and ?. Cell Metab 2007, 5:345-356.
74. ? directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab 2007, 6:13-24.
75. Arany Z., He H., Lin J., et al. Transcriptional coactivator PGC-1? controls the energy state and contractile function of cardiac muscle. Cell Metab 2005, 1:259-271.
76. Lehman J.J., Boudina S., Banke N.H., et al. The transcriptional coactivator PGC-1? is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol 2008, 295(1):H185-H196.
77. Arany Z., Novikov M., Chin S., et al. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR? coactivator 1?. Proc Natl Acad Sci U S A 2006, 103(26):10086-10091.
78. Hansson A., Hance N., Dufour E., et al. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci U S A 2004, 101(9):3136-3141.
79. van den Bosch B.J., van den Burg C.M., Schoonderwoerd K., et al. Regional absence of mitochondria causing energy depletion in the myocardium of muscle LIM protein knockout mice. Cardiovasc Res 2005, 65(2):411-418.
80. Saupe K.W., Spindler M., Hopkins J.C., et al. Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart. J Biol Chem 2000, 275(26):19742-19746.
81. Saupe K.W., Spindler M., Tian R., et al. Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ Res 1998, 82(8):898-907.
82. Lehman J.J., Barger P.M., Kovacs A., et al. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 2000, 106(7):847-856.
83. Russell L.K., Mansfield C.M., Lehman J.J., et al. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1? promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res 2004, 94(4):525-533.
84. Shen W., Spindler M., Higgins M., et al. The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system. J Mol Cell Cardiol 2005, 39(3):537-544.
85. Tian R., Christe M.E., Spindler M., et al. Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J Clin Invest 1997, 99(4):745-751.
86. Tian R., Nascimben L., Ingwall J.S., et al. Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts. Circulation 1997, 96(4):1313-1319.
87. Herrmann G., Decherd M. The chemical nature of heart failure. Ann Intern Med 1939, 12:1233-1244.
88. Pool P.E., Spann J.F., Buccino R.A., et al. Myocardial high energy phosphate stores in cardiac hypertrophy and heart failure. Circ Res 1967, 21(3):365-373.
89. Ingwall J.S. The hypertrophied myocardium accumulates the MB-creatine kinase isozyme. Eur Heart J 1984, 5(suppl. F):129-139.
90. Sykut-Cegielska J., Gradowska W., Mercimek-Mahmutoglu S., et al. Biochemical and clinical characteristics of creatine deficiency syndromes. Acta Biochim Pol 2004, 51(4):875-882.
91. Neubauer S., Remkes H., Spindler M., et al. Down regulation of the Na(+)-creatine co-transporter in failing human myocardium and in experimental heart failure. Circulation 1999, 100:1847-1850.
92. Ten Hove M., Chan S., Lygate C., et al. Mechanisms of creatine depletion in chronically failing rat heart. J Mol Cell Cardiol 2005, 38(2):309-313.
93. Cullen M.E., Yuen A.H., Felkin L.E., et al. Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation 2006, 114(suppl. 1):I16-I20.
94. Braissant O., Henry H., Villard A.M., et al. Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC Dev Biol 2005, 5(1):9.
95. Boehm E., Chan S., Monfared M., et al. Creatine transporter activity and content in the rat heart supplemented by and depleted of creatine. Am J Physiol Endocrinol Metab 2003, 284(2):E399-E406.
96. Strutz-Seebohm N., Shojaiefard M., Christie D., et al. PIKfyve in the SGK1 mediated regulation of the creatine transporter SLC6A8. Cell Physiol Biochem 2007, 20(6):729-734.
97. Weiss R.G., Chatham J.C., Georgakopolous D., et al. An increase in the myocardial PCr/ATP ratio in GLUT4 null mice. FASEB J 2002, 16(6):613-615.
98. Tran T.T., Dai W., Sarkar H.K. Cyclosporin A inhibits creatine uptake by altering surface expression of the creatine transporter. J Biol Chem 2000, 275(46):35708-35714.
99. Pinz I., Ostroy S.E., Hoyer K., et al. Calcineurin-induced energy wasting in a transgenic mouse model of heart failure. Am J Physiol Heart Circ Physiol 2008, 294(3):H1459-H1466.
100. Weiss R.G., Gerstenblith G., Bottomley P.A. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A 2005, 102(3):808-813.
101. ten Hove M., Lygate C.A., Fischer A., et al. Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice. Circulation 2005, 111(19):2477-2485.
102. Wallis J., Lygate C.A., Fischer A., et al. Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice. Circulation 2005, 112(20):3131-3139.
103. Crozatier B., Badoual T., Boehm E., et al. Role of creatine kinase in cardiac excitation-contraction coupling: studies in creatine kinase-deficient mice. FASEB J 2002, 16(7):653-660.
104. Nahrendorf M., Streif J.U., Hiller K.H., et al. Multimodal functional cardiac MRI in creatine kinase-deficient mice reveals subtle abnormalities in myocardial perfusion and mechanics. Am J Physiol Heart Circ Physiol 2006, 290(6):H2516-H2521.
105. Lygate C.A., Hunyor I., Medway D., et al. Cardiac phenotype of mitochondrial creatine kinase knockout mice is modified on a pure C57BL/6 genetic background. J Mol Cell Cardiol 2009, 46(1):93-99.
106. Park S.J., Zhang J., Ye Y., et al. Myocardial creatine kinase expression after left ventricular assist device support. J Am Coll Cardiol 2002, 39(11):1773-1779.
107. Smith S.H., Kramer M.F., Reis I., et al. Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy. Circ Res 1990, 67(6):1334-1344.
108. Janssen E., Dzeja P.P., Oerlemans F., et al. Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. EMBO J 2000, 19(23):6371-6381.
109. Tian R., Ingwall J.S. Energetic basis for reduced contractile reserve in isolated rat hearts. Am J Physiol 1996, 270(4 pt 2):H1207-H1216.
110. Hopkins J., Miao W., Ingwall J. Paradoxical effects of creatine kinase deletion on systolic and diastolic function in ischemia. Circulation 1998, 98(17):I-758.
111. Horn M., Remkes H., Stromer H., et al. Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction. Circulation 2001, 104(15):1844-1849.
112. Brixius K., Lu R., Boelck B., et al. Chronic treatment with carvedilol improves Ca(2+)-dependent ATP consumption in triton X-skinned fiber preparations of human myocardium. J Pharmacol Exp Ther 2007, 322(1):222-227.
113. Tuunanen H., Engblom E., Naum A., et al. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 2006, 114(20):2130-2137.
114. Lamberts R.R., Caldenhoven E., Lansink M., et al. Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy in rats. Am J Physiol Heart Circ Physiol 2007, 293(3):H1869-H1876.
115. Maccarter D., Vijay N., Washam M., et al. D-ribose aids advanced ischemic heart failure patients. Int J Cardiol, 137, 79-80 2008.
116. Liao R., Nascimben L., Friedrich J., et al. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res 1996, 78(5):893-902.
117. Ingwall J.S. ATP and the heart: an overview. ATP and the heart 2002, Kluwer Academic, Norwell, Mass.